期刊文献+

类风湿关节炎患者血清可溶性髓样细胞触发受体-1、白介素-17水平研究 被引量:3

The Soluble Triggering Receptors Expressed on Myeloid Cells-1,sTREM-1 Interleukin-17 of Rheumatoid Arthritis Patients
下载PDF
导出
摘要 目的:对类风湿关节炎(RA)患者血清可溶性髓样细胞触发受体-1、白介素-17水平进行研究。方法:选取本院2010年1月-2012年12月住院部和门诊收治的类风湿关节炎患者50例(观察组),将50例患者按照DSA28的评分大小分为活动组和非活动组,并另选取同一时间在本院进行体检的健康者50例为对照组,应用酶联免疫吸附试验法(ELISA)对所有患者的TREM-1和IL-17进行检验,并同时检测观察组患者的RHF、CRP、CCP以及C3水平。结果:观察组的TREM-1和IL-17水平明显大于对照组(P<0.05);活动组的TREM-1水平明显大于非活动组(P<0.05),活动组和非活动组IL-17水平比较差异无统计学意义(P>0.05)。对RA患者活动组和非活动组各项血清指标的比较:CCP和RHF指标组间比较差异均无统计学意义(P>0.05);而CRP、C3指标比较差异均有统计学意义(P<0.05)。结论:TREM-1指标在RA患者中呈高表达,TREM-1可以作为反映RA患者病情活动的重要指标,且IL-17和TREM-1之间可协同作用。 Objective:To study serum soluble myeloid cells trigger receptor-1 interleukin-17 level of rheumatoid arthritis patients.Method:50 patients(treatment group)with rheumatoid arthritis inpatient and outpatient were chosen from our hospital from January 2010 to December 2012. According to DSA28 ratings,50 cases were devided into active and inactive groups,at the same time 50 cases of healthy subjects were chosen in the hospital for a control group.The levels of TREM-1 and IL-17 of the four groups patients were tested by using enzyme-linked immunosorbent assay(ELISA). At the same time,the RHF,CRP,CCP and C3 level of the treatment group patients were detected.Result:The TREM-1 and IL-17 levels of the treatment group was significantly greater than that of the control group(P〈0.05);the TREM-1 level of the active group was significantly greater than that of inactive group(P〈0.05).There was no significant difference in CCP and RHF between the active and inactive groups in RA patients(P〉0.05),but there was obvious difference of CRP and C3(P〈0.05).Conclusion:The TREM-1 indexes is high in patients with RA,TREM-1 can be used as an important index of disease activity in patients with RA,and IL-17 and TREM-1 can synergy each other.
出处 《中国医学创新》 CAS 2013年第32期15-17,共3页 Medical Innovation of China
关键词 类风湿关节炎 血清 可溶性髓样细胞触发受体-1 白介素-17 Rheumatoid arthritis Serum Soluble myeloid cells Trigger receptor-1 Interleukin-17
  • 相关文献

参考文献15

二级参考文献147

  • 1王霖,王文杰.破骨细胞在类风湿性关节炎骨破坏中的作用及其调控机制[J].生理科学进展,2004,35(3):269-272. 被引量:37
  • 2王峰,黄安斌.IL-17在类风湿性关节炎中的作用[J].国际骨科学杂志,2006,27(5):301-303. 被引量:12
  • 3李玉吉,申建军,王承祥.全髋关节置换术后肿瘤坏死因子-α和黏附分子-1的变化及意义[J].中国医师进修杂志,2006,29(9):15-16. 被引量:3
  • 4Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol, 2002, 71: 1-8.
  • 5Starnes T, Broxmeyer HE, Robertson M J, et al. Cutting edge: IL- 17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol, 2002, 169: 642- 646.
  • 6Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med, 2007, 13: 139-145.
  • 7Lubberts E, Koenders MI, van den Berg WB. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther, 2005, 7: 29-37.
  • 8Ivaylo Il, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentialion program of proinflammalory IL-17^+ T helper cells. Cell, 2006, 126:1121-1133.
  • 9Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest, 2006. 116: 1218-1222.
  • 10Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol, 2006, 18: 349-356.

共引文献77

同被引文献49

  • 1Bouehon A, Facchetti F,Weigand MA, et al. TREM-1 am- plifies inflammation and is a crucialmediator of septic shock [J]. Nature, 2001, 410: 1103-1107.
  • 2Latour -P6rez J, Alcald -L6pez Diagnostic accuracy of sTREM A, Garcla-Garcia MA, eta! 1 to identify infection in criti cally ill patients with systemic inflammatory response syn drome[J]. Clin Biochem, 2010, 43:720 -724.
  • 3Turnbu 11 IR, Mcdunn JE, Takai T, etaL DAP12( KARAP ) amplifies inflamination and in -creases mortality from endo- toxemia and septic peritonitis [J]. J Exp Med, 2005, 202: 363-369.
  • 4Li JF, Wang L, Wang L, et al. The Treg/Thl7 imbalance in patients with idiopathic dilated cardiomyopathy. [J]. Scand J Immunol. 2010 Apr, 71(4) :298-303.
  • 5Barati M, Bashar FR, Shahrami R, et al. Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sep- sis[J]. J Crit Care, 2010, 25:362. e7-362, e11.
  • 6Kim K S, Tracy S,Tapprich W, et at. 5 -terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA [J]. J Virol, 2005, 79: 7024- 7041.
  • 7Gibot S, Cravoisy A. Soluble form of the triggering receptor expressed on myeloid cells-I as a marker of microbial infection [J]. ClinMedRes, 2004, 2: 181-187.
  • 8Phua J, Koay ES, ZhangD,et al. Solube triggering receptor expressed on myeloid cel-ll in acute respiratory infections[J]. Eur Respir, 2009, 28: 695-702.
  • 9Ireland N, Kalkoff M, Cursons RT, et al. Messenger RNA expression of multiple immune mediators in leukoeytes from elective orthopaedic surgical patients[J]. Anaesth Intens Ire Care, 2004, 32: 188-195.
  • 10G ibot S, Kolopp-Sarda MN, Bene MC, et al. Plasma level of a triggering receptor expressed on myeloid cells-1 : its diag- nostic accuracy in patients with suspected sepsis[J]. Ann In tern Med, 2004,141: 9-15.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部